Nk. Kalyan et al., IMMUNOGENICITY OF RECOMBINANT INFLUENZA-VIRUS HEMAGGLUTININ CARRYING PEPTIDES FROM THE ENVELOPE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Vaccine, 12(8), 1994, pp. 753-760
Haemagglutinin (HA), the major surface glycoprotein of influenza virus
, is a potent immunogen against which viral neutralizing antibodies ar
e directed. Studies of the three-dimensional structure of HA have iden
tified major antigenic sites on the molecule. We have exploited HA as
a carrier for small antigenic regions (epitopes) of the HIV-1 envelope
(env) glycoprotein. Using recombinant DNA techniques, the epitopes we
re inserted in-frame into a known antigenic site of HA to produce HA-e
pitope chimeras. Guinea-pigs and mice immunized with these chimeras in
combination with adjuvant generated significant immune responses agai
nst the carrier HA and also produced epitope-specific antibodies that
recognized the native whole HIV-1 env. One of the chimeras which conta
ined a V3-loop sequence of HIV-1 env elicited neutralizing antibodies
against the homologous strain of HIV-1. The antibodies against HA and
the inserted epitopes remained at high levels for up to 72 weeks. Rema
rkably, these responses were generated with low doses of immunogens co
ntaining only nanogram quantities of the inserted epitopes. These resu
lts suggest the utility of HA as a carrier to allow selective antibody
induction against foreign epitopes, and offer a new approach for vacc
ine development as well as for the production of monospecific antibodi
es useful in diagnostics and research.